| Trial ID: | L2904 |
| Source ID: | NCT01538589
|
| Associated Drug: |
Insulin Aspart
|
| Title: |
Special Survey for Patients With Type 1 or Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin aspart
|
| Outcome Measures: |
Primary: Occurrence of severe hypoglycaemic symptoms, Year 1|Occurrence of severe hypoglycaemic symptoms, Year 2 for patients who had an antibody titre test performed|Antibody titre findings, Year 1|Antibody titre findings, Year 2 for patients who had an antibody titre test performed|Adverse events, Year 1|Adverse events, Year 2 for patients who had an antibody titre test performed | Secondary: Response rate assessed by the investigator: Ability or failure to achieve expected glycaemic control, Year 1|Response rate assessed by the investigator: Ability or failure to achieve expected glycaemic control, Year 2 for patients who had an antibody titre test performed|HbA1c (glycosylated haemoglobin), Year 1|HbA1c (glycosylated haemoglobin), Year 2 for patients who had an antibody titre test performed|Total dose of insulin infused subcutaneously, Year 1|Total dose of insulin infused subcutaneously, Year 2 for patients who had an antibody titre test performed
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
1582
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2003-12
|
| Completion Date: |
2009-10
|
| Results First Posted: |
|
| Last Update Posted: |
2016-03-07
|
| Locations: |
Tokyo, 1000005, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT01538589
|
